25747-05-1O=S(=O)(O)c1cc(O)c(N=Nc2ccc3ccccc3c2O)c2ccccc12BRDGZOLJYALNOY-UHFFFAOYSA-NT611 is an investigational oral anti-cytomegalovirus (CMV) drug candidate.
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
T611 is an oral anti-cytomegalovirus (CMV) drug candidate. T611 inhibits a CMV enzyme that is essential for viral replication. The new study will explore the efficacy of T611 in HIV/AIDS patients with CMV infection. CMV is a ubiquitous herpes virus that causes serious disease in immuno-compromised patients.
Loading…
Loading…
No reaction records under the current filter.
Loading…
25747-05-1、350595-61-8DTXSID5067136CHEMBL420168